Global Oxaliplatin Market Research Report 2023(Status and Outlook)
Report Overview
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Global Oxaliplatin Market Size was estimated at USD 897.50 million in 2022 and is projected to reach USD 1630.16 million by 2029, exhibiting a CAGR of 8.90% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Oxaliplatin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oxaliplatin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oxaliplatin market in any manner.
Global Oxaliplatin Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
Market Segmentation (by Type)
Mannitol
Glucose Solution
Lactose Solution
Others
Oxaliplatin
Market Segmentation (by Application)
Catalyst
Electroplating
Ceramic Colorant
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oxaliplatin Market
Overview of the regional outlook of the Oxaliplatin Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Oxaliplatin
- 1.2 Key Market Segments
- 1.2.1 Oxaliplatin Segment by Type
- 1.2.2 Oxaliplatin Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Oxaliplatin Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Oxaliplatin Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Oxaliplatin Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Oxaliplatin Market Competitive Landscape
- 3.1 Global Oxaliplatin Sales by Manufacturers (2018-2023)
- 3.2 Global Oxaliplatin Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Oxaliplatin Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Oxaliplatin Sales Sites, Area Served, Product Type
- 3.6 Oxaliplatin Market Competitive Situation and Trends
- 3.6.1 Oxaliplatin Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Oxaliplatin Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Oxaliplatin Industry Chain Analysis
- 4.1 Oxaliplatin Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Oxaliplatin Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Oxaliplatin Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Oxaliplatin Sales Market Share by Type (2018-2023)
- 6.3 Global Oxaliplatin Market Size Market Share by Type (2018-2023)
- 6.4 Global Oxaliplatin Price by Type (2018-2023)
- 7 Oxaliplatin Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Oxaliplatin Market Sales by Application (2018-2023)
- 7.3 Global Oxaliplatin Market Size (M USD) by Application (2018-2023)
- 7.4 Global Oxaliplatin Sales Growth Rate by Application (2018-2023)
- 8 Oxaliplatin Market Segmentation by Region
- 8.1 Global Oxaliplatin Sales by Region
- 8.1.1 Global Oxaliplatin Sales by Region
- 8.1.2 Global Oxaliplatin Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Oxaliplatin Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Oxaliplatin Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Oxaliplatin Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Oxaliplatin Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Oxaliplatin Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Sanofi-Aventis
- 9.1.1 Sanofi-Aventis Oxaliplatin Basic Information
- 9.1.2 Sanofi-Aventis Oxaliplatin Product Overview
- 9.1.3 Sanofi-Aventis Oxaliplatin Product Market Performance
- 9.1.4 Sanofi-Aventis Business Overview
- 9.1.5 Sanofi-Aventis Oxaliplatin SWOT Analysis
- 9.1.6 Sanofi-Aventis Recent Developments
- 9.2 Yakult honsha
- 9.2.1 Yakult honsha Oxaliplatin Basic Information
- 9.2.2 Yakult honsha Oxaliplatin Product Overview
- 9.2.3 Yakult honsha Oxaliplatin Product Market Performance
- 9.2.4 Yakult honsha Business Overview
- 9.2.5 Yakult honsha Oxaliplatin SWOT Analysis
- 9.2.6 Yakult honsha Recent Developments
- 9.3 Dr Reddy's laboratories
- 9.3.1 Dr Reddy's laboratories Oxaliplatin Basic Information
- 9.3.2 Dr Reddy's laboratories Oxaliplatin Product Overview
- 9.3.3 Dr Reddy's laboratories Oxaliplatin Product Market Performance
- 9.3.4 Dr Reddy's laboratories Business Overview
- 9.3.5 Dr Reddy's laboratories Oxaliplatin SWOT Analysis
- 9.3.6 Dr Reddy's laboratories Recent Developments
- 9.4 Sun Pharmaceutical
- 9.4.1 Sun Pharmaceutical Oxaliplatin Basic Information
- 9.4.2 Sun Pharmaceutical Oxaliplatin Product Overview
- 9.4.3 Sun Pharmaceutical Oxaliplatin Product Market Performance
- 9.4.4 Sun Pharmaceutical Business Overview
- 9.4.5 Sun Pharmaceutical Oxaliplatin SWOT Analysis
- 9.4.6 Sun Pharmaceutical Recent Developments
- 9.5 Teva
- 9.5.1 Teva Oxaliplatin Basic Information
- 9.5.2 Teva Oxaliplatin Product Overview
- 9.5.3 Teva Oxaliplatin Product Market Performance
- 9.5.4 Teva Business Overview
- 9.5.5 Teva Oxaliplatin SWOT Analysis
- 9.5.6 Teva Recent Developments
- 9.6 Fresenius Kabi
- 9.6.1 Fresenius Kabi Oxaliplatin Basic Information
- 9.6.2 Fresenius Kabi Oxaliplatin Product Overview
- 9.6.3 Fresenius Kabi Oxaliplatin Product Market Performance
- 9.6.4 Fresenius Kabi Business Overview
- 9.6.5 Fresenius Kabi Recent Developments
- 9.7 Hospira
- 9.7.1 Hospira Oxaliplatin Basic Information
- 9.7.2 Hospira Oxaliplatin Product Overview
- 9.7.3 Hospira Oxaliplatin Product Market Performance
- 9.7.4 Hospira Business Overview
- 9.7.5 Hospira Recent Developments
- 9.8 Mylan
- 9.8.1 Mylan Oxaliplatin Basic Information
- 9.8.2 Mylan Oxaliplatin Product Overview
- 9.8.3 Mylan Oxaliplatin Product Market Performance
- 9.8.4 Mylan Business Overview
- 9.8.5 Mylan Recent Developments
- 9.9 Jiangsu Hengrui Medicine
- 9.9.1 Jiangsu Hengrui Medicine Oxaliplatin Basic Information
- 9.9.2 Jiangsu Hengrui Medicine Oxaliplatin Product Overview
- 9.9.3 Jiangsu Hengrui Medicine Oxaliplatin Product Market Performance
- 9.9.4 Jiangsu Hengrui Medicine Business Overview
- 9.9.5 Jiangsu Hengrui Medicine Recent Developments
- 9.10 Nanjing Pharmaceutical Factory
- 9.10.1 Nanjing Pharmaceutical Factory Oxaliplatin Basic Information
- 9.10.2 Nanjing Pharmaceutical Factory Oxaliplatin Product Overview
- 9.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Product Market Performance
- 9.10.4 Nanjing Pharmaceutical Factory Business Overview
- 9.10.5 Nanjing Pharmaceutical Factory Recent Developments
- 9.11 Jiangsu Aosaikang Pharmaceutical
- 9.11.1 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Basic Information
- 9.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Overview
- 9.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Market Performance
- 9.11.4 Jiangsu Aosaikang Pharmaceutical Business Overview
- 9.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
- 9.12 Qilu Pharmaceutical
- 9.12.1 Qilu Pharmaceutical Oxaliplatin Basic Information
- 9.12.2 Qilu Pharmaceutical Oxaliplatin Product Overview
- 9.12.3 Qilu Pharmaceutical Oxaliplatin Product Market Performance
- 9.12.4 Qilu Pharmaceutical Business Overview
- 9.12.5 Qilu Pharmaceutical Recent Developments
- 9.13 Hisun Pharmaceutical
- 9.13.1 Hisun Pharmaceutical Oxaliplatin Basic Information
- 9.13.2 Hisun Pharmaceutical Oxaliplatin Product Overview
- 9.13.3 Hisun Pharmaceutical Oxaliplatin Product Market Performance
- 9.13.4 Hisun Pharmaceutical Business Overview
- 9.13.5 Hisun Pharmaceutical Recent Developments
- 9.14 Lunan Pharmaceutical
- 9.14.1 Lunan Pharmaceutical Oxaliplatin Basic Information
- 9.14.2 Lunan Pharmaceutical Oxaliplatin Product Overview
- 9.14.3 Lunan Pharmaceutical Oxaliplatin Product Market Performance
- 9.14.4 Lunan Pharmaceutical Business Overview
- 9.14.5 Lunan Pharmaceutical Recent Developments
- 9.15 Luoxin
- 9.15.1 Luoxin Oxaliplatin Basic Information
- 9.15.2 Luoxin Oxaliplatin Product Overview
- 9.15.3 Luoxin Oxaliplatin Product Market Performance
- 9.15.4 Luoxin Business Overview
- 9.15.5 Luoxin Recent Developments
- 9.16 Halfsky Pharmacy
- 9.16.1 Halfsky Pharmacy Oxaliplatin Basic Information
- 9.16.2 Halfsky Pharmacy Oxaliplatin Product Overview
- 9.16.3 Halfsky Pharmacy Oxaliplatin Product Market Performance
- 9.16.4 Halfsky Pharmacy Business Overview
- 9.16.5 Halfsky Pharmacy Recent Developments
- 9.17 YRPG
- 9.17.1 YRPG Oxaliplatin Basic Information
- 9.17.2 YRPG Oxaliplatin Product Overview
- 9.17.3 YRPG Oxaliplatin Product Market Performance
- 9.17.4 YRPG Business Overview
- 9.17.5 YRPG Recent Developments
- 9.18 Hainan Jinrui Pharmaceutical
- 9.18.1 Hainan Jinrui Pharmaceutical Oxaliplatin Basic Information
- 9.18.2 Hainan Jinrui Pharmaceutical Oxaliplatin Product Overview
- 9.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Product Market Performance
- 9.18.4 Hainan Jinrui Pharmaceutical Business Overview
- 9.18.5 Hainan Jinrui Pharmaceutical Recent Developments
- 9.19 Jari Pharmaceutical
- 9.19.1 Jari Pharmaceutical Oxaliplatin Basic Information
- 9.19.2 Jari Pharmaceutical Oxaliplatin Product Overview
- 9.19.3 Jari Pharmaceutical Oxaliplatin Product Market Performance
- 9.19.4 Jari Pharmaceutical Business Overview
- 9.19.5 Jari Pharmaceutical Recent Developments
- 9.20 Chiatai Tianqing
- 9.20.1 Chiatai Tianqing Oxaliplatin Basic Information
- 9.20.2 Chiatai Tianqing Oxaliplatin Product Overview
- 9.20.3 Chiatai Tianqing Oxaliplatin Product Market Performance
- 9.20.4 Chiatai Tianqing Business Overview
- 9.20.5 Chiatai Tianqing Recent Developments
- 10 Oxaliplatin Market Forecast by Region
- 10.1 Global Oxaliplatin Market Size Forecast
- 10.2 Global Oxaliplatin Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Oxaliplatin Market Size Forecast by Country
- 10.2.3 Asia Pacific Oxaliplatin Market Size Forecast by Region
- 10.2.4 South America Oxaliplatin Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Oxaliplatin by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Oxaliplatin Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Oxaliplatin by Type (2024-2029)
- 11.1.2 Global Oxaliplatin Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Oxaliplatin by Type (2024-2029)
- 11.2 Global Oxaliplatin Market Forecast by Application (2024-2029)
- 11.2.1 Global Oxaliplatin Sales (K MT) Forecast by Application
- 11.2.2 Global Oxaliplatin Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook